Back to Blog
Sidiary 6 crack5/31/2023 ![]() ![]() → Swiss gene therapy player Anjarium Biosciences jumped into the gene therapy 2.0 fray with a Series A in September 2021 that featured contributions from Abingworth, Gimv and Pfizer’s venture arm, and this week Stephen Yoo has hitched a ride as CEO. “Illumina’s lawsuit frivolously challenges our ownership and authorship of our intellectual property, which is the backbone of our vital work,” Guardant Health general counsel John Saia said in a March statement. Its co-founders and co-CEOs, Helmy Eltoukhy and AmirAli Talasaz, are former staffers at Illumina, which is alleging that the pair infringed on intellectual property to develop Guardant’s technology. Guardant Health, a primary liquid biopsy screening test competitor, filed a motion to dismiss Illumina’s case against the company in late May. Goswami joined Francis deSouza’s crew in 2019 as SVP of corporate development and strategic planning after his time as president of Thermo Fisher’s clinical next-generation sequencing (NGS) and oncology business unit. → Sam Samad is out as CFO of Illumina as chief strategy and corporate development officer Joydeep Goswami slides in for him on an interim basis starting July 8.
0 Comments
Read More
Leave a Reply. |